Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
13, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced a research collaboration with Amgen to study barriers to care and patients' treatment experience
These studies will provide further insights into the drugs long-term impact and help refine its use in clinical practice
What women reported: 57% said their cycles became more regular 24% reported lighter periods Around 13% experienced more irregular cycles, heavier periods, or missed periods Some things improved, some got worse. Mira survey participant What this means GLP-1 medications may influence hormonal patterns but effects move in different directions and outcomes are not uniform
Short-chain fatty acids suppress food intake by activating vagal afferent neurons
Eating smaller, more frequent meals rather than large portions can help minimise nausea and abdominal discomfort
PRESENTED at the American College of Gastroenterology (ACG) Annual Meeting, new research suggests that GLP-1 receptor agonists (GLP-1RAs) may significantly lower the risk of pancreatic cancer in drug-naive patients with type 2 diabetes (T2D) compared to other antidiabetic treatments
US$ 28.77
US$ 23.15
US$ 20.69
US$ 25.60
US$ 23.96
US$ 25.61
US$ 25.80
US$ 25.12
